BlackRock’s Amgen AMGN Stock Holding History

BlackRock’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-600	Closed	-$100K	–	3728
2016 Q3	$100K	Buy	+600	New	+$101K	﹤0.01%	2590

Other funds holding AMGN

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock's AMGN Position: Q2 2026 in Review

BlackRock increased its Amgen (AMGN) stake by 4.8% in Q2 2026, buying an estimated $774M and bringing the position to 49,362,016 shares worth $17.9B. The position accounts for 0.27% of the portfolio, ranked #56.

BlackRock first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

BlackRock held 49,362,016 shares of Amgen worth $17.9B as of Q2 2026.
BlackRock bought 2,261,544 Amgen shares in Q2 2026, an estimated $774M.
Amgen made up 0.27% of BlackRock's portfolio in Q2 2026, its #56 holding.
BlackRock first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.